🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Status
Completed
Location
Piedmont Cancer Institute, P.C.
Start Date
2019-12-05
Trial ID
NCT04179396
Treatments Being Tested
This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2018-05-14
Trial ID
NCT03522246
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
The goal of this clinical trial is to learn about the tolerability of telmi...
Status
Recruiting
Location
Dartmouth Health
Start Date
2024-04-22
Trial ID
NCT06168487
Treatments Being Tested
This is a single arm Phase Ib/II, open label, safety, pharmacokinetic and e...
Status
Active Not Recruiting
Location
Helen Diller Family Comprehensive Cancer Center University of California San Francisco
Start Date
2020-04-03
Trial ID
NCT04253262
Treatments Being Tested
The purpose of the ATLAS study is to determine how patients with locally ad...
Status
Terminated
Location
Pinnacle Oncology, Honor Health
Start Date
2018-06-01
Trial ID
NCT03397394
Treatments Being Tested
Investigators hypothesize that following first-line platinum based chemothe...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2019-03-28
Trial ID
NCT03639935
Dose escalation phase 1 study of PARP inhibitor PF-01367338 in combination ...
Status
Completed
Location
Churchill Hospital
Start Date
2010-02
Trial ID
NCT01009190
Treatments Being Tested
The purpose of this study is to find out whether combining the study drugs ...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-11-05
Trial ID
NCT04624178
The purpose of this study is to assess the efficacy of a PARP inhibitor, ru...
Status
Completed
Location
Centre Leon Berard
Start Date
2016-03
Trial ID
NCT02505048
Treatments Being Tested